Sb Investment Advisers (Uk) LTD Roivant Sciences Ltd. Transaction History
Sb Investment Advisers (Uk) LTD
- $12.1 Billion
- Q3 2024
A detailed history of Sb Investment Advisers (Uk) LTD transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Sb Investment Advisers (Uk) LTD holds 65,934,074 shares of ROIV stock, worth $767 Million. This represents 6.27% of its overall portfolio holdings.
Number of Shares
65,934,074
Previous 71,361,388
7.61%
Holding current value
$767 Million
Previous $754 Million
0.87%
% of portfolio
6.27%
Previous 6.97%
Shares
6 transactions
Others Institutions Holding ROIV
# of Institutions
306Shares Held
510MCall Options Held
1.05MPut Options Held
2.25M-
Qvt Financial LP New York, NY65.8MShares$766 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$630 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$485 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$412 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.7MShares$345 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.2B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...